7 Reasons This Swiss Beauty Chocolate Is Trending With Women in Perimenopause in 2026

Oestrogen falls. Your skin’s ceramides fall with it.

Ceramides are the lipid mortar holding your skin cells together and holding water in. Their production is oestrogen-dependent.

So when oestrogen drops through perimenopause, ceramides don’t drift downward, they fall. Water escapes faster than it’s replaced. The barrier thins. Everything you apply on top starts absorbing unevenly onto a surface that’s structurally different from the one you had at 40.

That’s why it felt sudden. It was sudden. Your skin didn’t age five years in eight months; it lost the thing that was holding it together.

This is why the products that always worked stopped working

You didn’t get worse at skincare. Your skincare got out-run.

Every product on your shelf was formulated for a barrier that still makes its own ceramides. It assumes the mortar is there and works on top of it. Once the mortar thins, the same cream on the same face gives a different result, and no amount of layering fixes a structural shortage from the outside.

This is the single most common thing women report at this stage, and it’s the most misdiagnosed. It isn’t the products. It’s the foundation they’re sitting on.

There’s a ceramide you take, not one you apply

Ceramosides®, a wheat polar lipid complex. Swallowed, absorbed through the gut, carried by your bloodstream to your skin, where it refills the ceramide pool from within.

Oestrogen isn’t refilling it. So it gets refilled another way.

It was tested on menopausal women. Specifically. As their own group.

This is the reason this page exists.

Kern C, et al. Journal of Cosmetic Dermatology, 2024. Double-blind, placebo-controlled, 72 women, 56 days. Measured with instruments, Corneometer for hydration, Tewameter for water loss, Cutometer for elasticity. Not questionnaires.

Across the full group:

• Moisturisation: +19% vs placebo
• Elasticity: +18% vs placebo
• p < 0.001
• First significant effect: Day 14

And then the part that matters here, the researchers broke out the menopausal women, n=31, and analysed them separately. In that subgroup, transepidermal water loss, the direct measure of a leaking barrier, dropped significantly versus placebo from Day 14.

SOOID’s dose is 70.65 mg/day. The trial’s was 70 mg. Same dose. That’s not a coincidence; it’s the entire design brief.

Most of this category tests on women in their twenties and lets you assume it transfers. This didn’t.

The effect outlasted the supplement

The trial didn’t stop at 56 days. They followed the women for another 56 days taking nothing.

At Day 112, eight weeks after the last capsule, the improvement was still measurable.

That tells you what kind of change this is. Not something sitting on your face until it’s washed off. Not something that dissolves on a schedule. The barrier was rebuilt, and it stayed rebuilt.

A second trial (n=64, women 45–60) followed wrinkle depth on crow’s feet and found a significant reduction vs placebo at Week 8, a full one-grade improvement on the clinical scale.

It isn’t collagen, and this year that stopped being a technicality

If you started a collagen powder when your skin changed, you should know what published this year.

A meta-analysis of 23 randomised controlled trials found the high-quality, independently funded studies showed no significant benefit for skin hydration, elasticity, or wrinkles. The positive results clustered in industry-funded, lower-quality studies.

SOOID has no collagen in it. Your skin’s problem at this stage isn’t a collagen shortage you can drink, it’s a ceramide shortage driven by a hormone, plus collagen being broken down faster than it’s rebuilt. Different mechanism. Different molecule. The one with the dose-matched, placebo-controlled, menopause-subgrouped trial is the one in the jar.

And before you ask: yes, Seppic funds the Ceramosides research, and Seppic makes Ceramosides. You should ask that. Here’s the honest answer: what the collagen meta-analysis actually punished wasn’t industry funding, it was weak design, unblinded, uncontrolled, self-reported. Kern is double-blind, placebo-controlled, instrument-measured. It’s the tier of study collagen kept failing. Judge it on the design, and check the DOI yourself: 10.1111/jocd.16130.

Three chocolates. Which is the only reason anyone finishes the course.

You are, at this point in life, probably already taking things. Vitamin D. Maybe magnesium. Possibly HRT. The last thing you need is another capsule to remember and resent.

Three small chocolates. No water. No mixing. ~1.5 kcal a day.

It sounds trivial and it’s the reason it works, this category’s real failure isn’t efficacy at week 8, it’s that nobody reaches week 8. Compliance is the active ingredient.

[GUARANTEE, 90 days, full refund.] Day 14 is when the trial saw its first significant change. You’ll know well before the window shuts.